drugset
drugset / Trial / NCT01734564

Phase II Study With Hiltonol and Dendritic Cells in Solid Tumors

NCT01734564 ↗

Phase 2 Completed 15 enrolled Clinica Universidad de Navarra, Universidad de Navarra
Non-randomizedSingle-groupOpen-labelTreatment

Summary

In this phase II study, patients with solid tumors will receive treatment with hiltonol and autologous dendritic cells.

Timeline

Start
2012-11
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Hiltonol Other / unclassified — Other
Subject autologous dendritic cells Cell therapy — Subcutaneous

Indications

neoplasm